GlassScriptPhysician profile
Roslyn M Stahl
NPI 1104944859
$2,902.74
in general payments reported to CMS, 2019-2025
19 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $28.02 · 2021: $363 · 2022: $422 · 2023: $673 · 2024: $717 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $911.20 | 2021-2023 | |
| Glaukos Corporation | $459.69 | 2023-2024 | Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Iaccess Precision Blade, Idose |
| Alcon Vision LLC | $312.88 | 2022-2025 | Rocklatan, Simbrinza, Rhopressa |
| Allergan, INC. | $287.13 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $187.89 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Abbvie INC. | $163.27 | 2022-2025 | Durysta |
| Amgen INC. | $139.29 | 2024-2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $78.44 | 2019-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $50.10 | 2024 | Tecnis Iol |
| Kala Pharmaceuticals, INC. | $42.07 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $40.81 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $37.69 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $36.66 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $36.15 | 2019-2022 | |
| Ocular Therapeutix, INC. | $31.90 | 2021-2024 | Dextenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $27.33 | 2019-2021 | |
| Biotissue Holdings INC. | $25.72 | 2025 | |
| Sight Sciences, INC. | $20.12 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Oyster Point Pharma, INC. | $14.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roslyn Stahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.